A Study of Safety and Efficacy of UNR844 Chloride (UNR844-Cl) Eye Drops in Subjects With Presbyopia.
Clinical trial NCT03809611 · COMPLETED
Trial details
- NCT number
- NCT03809611
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-26
- Primary completion
- 2019-12-16
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.